Table 1.
Inclusion criteria: Full list of the inclusion and exclusion criteria of the study
Eligibility criteria | |
1. Previous digital mammography and ultrasound and magnetic resonance imaging | |
2. Suspicious or malignant diagnosis by FNAC (C4 or C5), by core biopsy (CB) or VABB (B4 or B5) | |
3. Dense breast (ACR class 3 or 4 on mammography) | |
4. Capable and willing to comply with study procedures, having signed the informed consent form | |
5. Breast size compatible with the dimensions of the image detector | |
6. In sufficiently good health to undergo standard breast cancer care and CESM examination | |
Exclusion criteria | |
1. High risk of adverse events related to iodinated contrast agents | |
2. Previously included in this study | |
3. Participating in, or having participated in another clinical trial(s) within the 30 days precedent | |
4. Previous breast reconstructive surgery or breast implant(s) | |
5. Concomitant or previous radiotherapy to the thorax area or systemic chemotherapy | |
6. Proven or supposed pregnancy |